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Background and aim: We tested the hypothesis that obesity reduced circulating number of endothelial progenitor
cells (EPCs), angiogenic ability, and blood flow in ischemic tissue that could be reversed after obesity control.
Methods: 8-week-old C57BL/6J mice (n = 27) were equally divided into group 1 (fed with 22-week control diet),
group 2 (22-week high fat diet), and group 3 (14-week high fat diet, followed by 8-week control diet). Critical limb
ischemia (CLI) was induced at week 20 in groups 2 and 3. The animals were sacrificed at the end of 22 weeks.
Results: Heart weight, body weight, abdominal fat weight, serum total cholesterol level, and fasting blood sugar
were highest in group 2 (all p< 0.001). The numbers of circulating EPCs (C-kit/CD31+, Sca-1/KDR+ and CXCR4/CD34+)
were lower in groups 1 and 2 than in group 3 at 18 h after CLI induction (p< 0.03). The numbers of differentiated EPCs
(C-kit/CD31+, CXCR4/CD34+ and CD133+) from adipose tissue after 14-day cultivation were also lowest in group 2
(p< 0.001). Protein expressions of VCAM-1, oxidative index, Smad3, and TGF-β were higher, whereas the Smad1/5 and
BMP-2, mitochondrial cytochrome-C SDF-1α and CXCR4 were lower in group 2 than in groups 1 and 3 (all p< 0.02).
Immunofluorescent staining of CD31+ and vWF+ cells, the number of small vessel (<15 μm), and blood flow through
Laser Doppler scanning of ischemic area were lower in group 2 compared to groups 1 and 3 on day 14 after CLI
induction (all p< 0.001).
Conclusion: Obesity suppressed abilities of angiogenesis and recovery from CLI that were reversed by obesity control.
Keywords: Obesity control, Endothelial progenitor cells, Angiogenesis, Critical limb ischemiaBackground
The dramatic increase in the prevalence of obesity is
mainly due to living in an environment characterized by
calorie-rich foods and lack of physical activity, especially in
Western countries [1]. Abundant data have demonstrated
that obesity predisposes to a variety of low-grade chronic
and systemic inflammatory diseases, including insulin re-
sistance, type 2 diabetes, fatty liver diseases, osteoarthritis,
atherosclerosis and its complications [2-7]. Epidemiologic* Correspondence: chyen0326@yahoo.com.tw; han.gung@msa.hinet.net
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reproduction in any medium, provided the origstudies have shown that obesity constitutes a major health
threat because of its associated morbidity and mortality,
especially those from cardiovascular diseases [8-10].
Studies have previously demonstrated that endothelial
progenitor cells (EPCs), which are premature hematopoietic
stem cells mobilized into systemic circulation from bone
marrow, are capable of differentiating into mature endothe-
lial cells for endothelial repair in blood vessels [11,12]. They
have been reported to migrate to ischemic area in response
to ischemia for angiogenesis/vasculogenesis, thereby enhan-
cing recovery of ischemia-related organ dysfunction [11-15].
Not only have EPCs been found to have a positive thera-
peutic impact on ischemic organ dysfunction in both clin-
ical [16] and experimental [17] settings, their circulating
levels have also been successfully used as clinical markers of
disease progression [18]. Studies have previously furthertd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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correlated with cumulative cardiovascular risk [13,19,20].
On the other hand, the impact of obesity, a risk factor for
cardiovascular diseases of growing importance, on endothe-
lial injury and dysfunction [21] as well as circulating num-
ber of endothelial progenitor cells (EPCs) [7,22] has not
been fully investigated, especially in the setting of a well-
controlled animal model study. Of particular significance in
translational research is that whether obesity control has a
positive impact on circulating number of EPCs, angiogen-
esis ability in response to ischemic insult, and tissue blood
flow under ischemic condition [23].
By using a high fat diet-induced obesity model, the aim
of this study was to test the hypotheses that, in obese
mice: 1) Ischemic stimulation leads to a decrease in the
number of circulating EPCs that can be reversed by obes-
ity control; 2) Tissue ischemia is accompanied by
impaired angiogenic capacity that is alleviated by improv-
ing obesity condition.Materials and methods
Ethics
All animal experimental procedures were approved by
the Institute of Animal Care and Use Committee at
Kaohsiung Chang Gang Memorial Hospital and
performed in accordance with the Guide for the Care
and Use of Laboratory Animals (NIH publication No.
85-23, National Academy Press, Washington, DC,
USA, revised 1996).Animal model of obesity
Eight-week-old male C57BL/6J mice (n = 24), weighing
22-24 gm, (Charles River Technology, BioLASCO
Taiwan Co., Ltd., Taiwan), were fed with high-fat diet (45
Kcal% fat; Research Diets, Inc) to create the diet-induced
obesity model for the purpose of this study. According
to the literature [24] and the instructions from the com-
pany (Research Diets, Inc), successful obesity induction
was defined as an increase in mouse body weight more
than 35% after 13 weeks’ feeding with the diet. Our study
showed that, by the end of 12 weeks of feeding with high
fat diet, 75% mice fit the criteria of obesity.
These 18 obese mice were then equally divided into group
2 (continuously fed with high fat diet for further 10 weeks –
obese group) and group 3 [continuously fed with high fat
diet for further 2 weeks, followed by standard mouse chow
(i.e. control diet) for 8 weeks – obesity control group]. An-
other group (group 1) of aged-matched C57BL/6J mice
(n=9) fed with control diet for the same duration (i.e., total
22-week control die), which was also purchased from the
same company (Research Diets, Inc), served as untreated
controls.Animal model of critical limb ischemia (CLI) for
stimulating EPC mobilization into circulation
By the end of 20 weeks after obesity induction, mice in
group 2 (obese), and group 3 (obesity control) were
anesthetized by inhalation of 2.0% isoflurane. Mice in group
1wihtout receiving CLI procedure served as normal con-
trols for comparing the molecular-cellular parameters and
blood flow in CLI area. The mice were placed in a supine
position on a warming pad at 37°C with the left hind limbs
shaved. Under sterile conditions, the left femoral artery,
small arterioles, and circumferential femoral artery were
exposed and ligated over their proximal and distal portions
before removal. Blood (0.3 mL in each mouse) was sampled
for quantification of EPCs using flow cytometry at 18 h and
day 14 after CLI induction before the animals were sacri-
ficed. To elucidate the baseline level of circulating EPCs,
blood sample (0.3 mL) was also collected 5 days prior to
CLI procedure in each group of mice.
Measurement of blood flow with laser Doppler
The detailed procedure has been described in our recent re-
port [25]. Briefly, the mice in groups 1, 2 and 3 were
anesthetized by inhalation of 2.0% isoflurane prior to CLI
induction and at days 2 and 14 after CLI procedure prior to
be sacrificed (n=9 for each group). Blood flow was assessed
in both inguinal areas and hind limbs by a Laser Doppler
scanner (moorLDLS, Moor, Co. UK) with the animals in a
supine position on a warming pad at 37°C. The ratio of
blood flow in left hind limb (ischemic) to that on the right
side (normal) was computed by the scanner. The mice were
sacrificed and the quadriceps muscle was collected for
Western blot analysis and immunofluorescent (IF) and
immunohistochemical (IHC) studies.
Flow cytometric quantification of endothelial progenitor
cells
For blood sampling at different time points (i.e. prior to CLI
and at 18 h and on day 14 after induction of CLI), cardiac
puncture instead of the venous route was adopted for blood
sampling using a 30# needle. A flow cytometic method for
identification of EPCs derived from peripheral blood has
been reported in our recent studies [17,18]. Briefly, the iso-
lated MNCs from 0.3 cc blood (3.0 x 105) were incubated
for 30 minutes at 4 0C in a dark room with monoclonal
antibodies against phycoerythrin (PE)- conjugated kinase in-
sert domain-conjugating receptor (KDR) (BD Biosciences),
the phycoerythrin (PE)- -conjugated CD34 (BD Bios-
ciences), the phycoerythrin (PE)-conjugated CD31 (BioLe-
gend), fluorescein isothiocyanate (FITC)-conjugated
CXCR4 (BD Biosciences), fluorescein isothiocyanate
(FITC)-conjugated sca-1 (BD Biosciences) and fluorescein
isothiocyanate (FITC)-conjugated c-kit (BD Biosciences) to
determine the EPC surface markers of c-kit/CD31, sca-1/
KDR, and CXCR4/CD34. The control ligand (IgG-PE
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and define a threshold for glycoprotein binding. For analysis
of KDR, the MNCs were further incubated with PE-conju-
gated anti-mouse antibody made in goat. After staining, the
MNCs were fixed in 1% of paraformaldehyde. Quantitative
two-colored flow cytometric analysis was performed using a
fluorescence-activated cell sorter (Beckman Coulter FC500
flow cytometer), i.e., using a method of double staining.
Each analysis included 8,000 cells per sample. The assays
for the EPCs in each sample were performed in duplicate,
with the mean level reported.
Isolation of adipose-derived endothelial progenitor cells
from mice
Following the CLI procedure, animals under inhalational
anesthesia of 2.0% isoflurane by the end of 20 weeks after
obesity induction, adipose tissue surrounding the epididymis
was carefully dissected and excised. Then 200-300 μL of ster-
ile saline was added to every 0.5 g of tissue to prevent dehy-
dration. The tissue was cut into< 1 mm3 size pieces using a
pair of sharp, sterile surgical scissors. Sterile saline (37˚C)
was added to the homogenized adipose tissue in a ratio of
3:1 (saline: adipose tissue), followed by the addition of stock
collagenase solution to a final concentration of 0.5 units/mL.
The centrifuge tubes with the contents were placed and
secured on aThermaline shaker and incubated with constant
agitation for 60±15 min at 37˚C. After 40 minutes of incu-
bation, the content was triturated with a 25 mL pipette for
2-3 minutes. The cells obtained were placed back to the
rocker for incubation. The contents of the flask were trans-
ferred to 50 mL tubes after digestion, followed by centrifuga-
tion at 600 g, for 5 minutes at room temperature. The fat
layer and saline supernatant from the tube were poured out
gently in one smooth motion or removed using vacuum suc-
tion. The cell pellet thus obtained was resuspended in
40 mL saline and then centrifuged again at 600 g for 5 min-
utes at room temperature. After being resuspended again in
5 mL saline, the cell suspension was filtered through a 100
μm filter into a 50 mL conical tube to which 2 mL of saline
was added to rinse the remaining cells through the filter.
The flow-through was pipetted into a new 50 mL conical
tube through a 40 μm filter. The tubes were centrifuged for
a third time at 600 g for 5 minutes at room temperature.
The cells were resuspended in saline. An aliquot of cell sus-
pension was then taken for cell culture in M199 culture
medium for two weeks. Flow cytometric analysis was then
performed for quantification of EPCs using double staining
(C-kit/CD31, Sca-1/KDR, CXCR4/CD34) and single stain
for CD133+ EPC after 2-week cell culture.
Isolation of mitochondria
The ischemic muscle was excised and washed with buffer
A (100 mM Tris-HCl, 70 mM sucrose, 10 mM EDTA,
and 210 mM mannitol, pH 7.4). Samples were mincedfinely in cold buffer A and incubated for 10 minutes. All
samples were homogenized in an additional 3 mL of buf-
fer A using a motor-driven grinder. The homogenate
was centrifuged twice at 700 g for 10 minutes at 4°C.
The supernatant was centrifuged again at 8,500 g for
15 min, and the pellets were washed with buffer B
(10 mM Tris-HCl, 70 mM sucrose, 1 mM EDTA, and
230 mM mannitol, pH 7.4). The mitochondria-rich pel-
lets were collected and stored at −70°C.
Western blot analysis
Equal amounts (10-30 μg) of protein extracts from ischemic
quadriceps of the animals were loaded and separated by
SDS-PAGE using 12% acrylamide gradients. The membranes
were incubated with monoclonal antibodies against intercel-
lular adhesion molecule (ICAM)-1 (1:100, Abcam), CXCR4
(1: 1000, Abcam), stromal cell-derived growth factor (SDF)-
1α (1: 1000, Cell Signaling), vascular endothelial growth fac-
tor (VEGF) (1: 1000, Abcam), phospho-Smad 3 (1:1000, Cell
Signaling), transforming growth factor (TGF)-β (1:500,
Abcam), phospho-Smad1/5 (1:1000, Cell Signaling), bone
morphogenic protein (BMP)-2 (1:500, Abcam), and cyto-
chrome c (Cyt c) (1: 2000, BD). Signals were detected with
HRP-conjugated goat anti- mouse or goat anti-rabbit IgG.
The Oxyblot Oxidized Protein Detection Kit was purchased
from Chemicon (S7150) for oxyblot protein analysis. Pro-
teins were transferred to nitrocellulose membranes which
were then incubated in the primary antibody solution (anti-
DNP 1: 150) for two hours, followed by incubation with sec-
ond antibody solution (1:300) for one hour at room
temperature. The washing procedure was repeated eight
times within 40 minutes. Immunoreactive bands were visua-
lized by enhanced chemiluminescence (ECL; Amersham
Biosciences) which was then exposed to Biomax L film
(Kodak). For quantification, ECL signals were digitized using
Labwork software (UVP). For oxyblot protein analysis, a
standard control was loaded on each gel.
Immunofluorescent (IF) staining
IF staining was performed for the examination of CD31+
and von Willebrand factor (vWF)+ cells, two endothelial
cell markers, using respective primary antibodies based on
our recent study [25]. Mouse control IgG (Abcam) and ir-
relevant monoclonal antibody against nuclear protein SC35
(Sigma) were used as the controls in the current study.
Vessel density in limb ischemic area
Immunohistochemical (IHC) staining of blood vessels
was performed with α-SMA (1:400) as primary antibody
at room temperature for 1 h, followed by washing with
PBS thrice. Ten minutes after the addition of the anti-
mouse-HRP conjugated secondary antibody, the tissue
sections were washed with PBS thrice. Then 3,3′ diami-
nobenzidine (DAB) (0.7 gm/tablet) (Sigma) was added,











26.3 ± 0.70 25.2 ± 0.61 25.2 ± 0.66 0.655
Final body
weight (g)
34.9 ± 1.42a 43.7 ± 1.50b 35.6 ± 2.19a <0.0001
Final abdominal
fat weight (g)




138.1 ± 10.2a 231.2 ± 7.59b 189.8 ± 7.55c <0.001
Initial blood glucose
(mg/dl)†
98.8 ± 9.4 102 ± 8.2 100.3 ± 8.6 0.667
Final blood glucose
(mg/dl)†
144.2 ± 17.4a 306.9 ± 71.4b 182.2 ± 18.8c <0.0001
C-kit/CD31 (%)
Baseline 1.06 ± 0.40 1.15 ± 0.21 1.21 ± 0.37 0.555
18 hour after CLI
procedure
1.20 ± 0.44a 2.60 ± 0.49b 4.11 ± 0.98c <0.0001
Day 14 after CLI
procedure
1.02 ± 1.01a 0.75 ± 0.23a 2.40 ± 0.82b 0.0019
Sca-1/KDR (%)
Baseline 0.66 ± 0.21 0.85 ± 0.27 0.73 ± 0.39 0.461
18 hour after CLI
procedure
0.87 ± 0.25a 1.15 ± 0.24a 1.88 ± 0.16b 0.006
Day 14 after CLI
procedure
0.56 ± 0.29 0.38 ± 0.20 0.89 ± 0.56 0.124
CXCR4/CD34 (%)
Baseline 0.43 ± 0.27 0.38 ± 0.17 0.56 ± 0.45 0.789
18 hour after CLI
procedure
0.54 ± 0.34a 0.68 ± 0.31a 1.34 ± 0.34b 0.006
Day 14 after CLI
procedure
0.63 ± 0.69 0.37 ± 0.19 0.79 ± 0.70 0.764
*: by one-way ANOVA on log transformed data.
Different letters (a, b, c) associated with different groups indicate significant
difference (at 0.05 level) by Tukey multiple comparison procedure.
† value was observed after 12 fasting in the mice.
C = control; CLI = critical limb ischemia.
Figure 1 Differentiation of adipose derived endothelial
progenitor cells (ADEPCs). A to D) Showing numbers of C-kit/
CD31+, CXCR4/CD34+, CD133+ and Sca-1/KDR+ EPCs after 14-day
cell culturing, respectively. * vs. other groups with different symbols
(i.e., * vs. † vs. {), p< 0.001. Statistical analysis by ANOVA followed by
Bonferroni multiple comparison post hoc test (n = 9 in each group).
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Finally, hematoxylin was added as a counter-stain for nu-
clei, followed by washing twice with PBS after one mi-
nute. Three sections of quadriceps were analyzed in each
mouse for quantification of small vessel (≤ 15.0 μm)
(200x) in ischemic region (for obese mice with and with-
out obesity reduction) and non-ischemic quadriceps (for
age-matched normal control). For quantification and
statistical analysis, three randomly selected high-power
fields [(HPFs) (200x)] were analyzed in each section
under the microscope. The mean number ± SD of small
vessels per HPF for each animal was then determined by
summation of all numbers divided by 9 (i.e., 3 sections x
3 randomly selected HPFs = 9). The procedure andprotocol for measurement of vessel density in limb is-
chemic region was based on our recent report [25].
Statistical analysis
Quantitative data are expressed as means±SD. Statistical
analysis was adequately performed by ANOVA followed by
Bonferroni’s multiple-comparisons post hoc test. Statistical
analysis was performed using SAS statistical software for
Windows version 8.2 (SAS institute, Cary, NC). A probabil-
ity value <0.05 was considered statistically significant.
Results
The baseline relevant variables
The initial body weight and fasting blood sugar were
similar among animals in group 1 (normal control),
group 2 (obese) and group 3 (obesity induction followed
by obesity control). However, the final body weight was
significantly higher in group 2 than in groups 1 and 3,
but it showed no difference between the later two groups
(Table 1). Additionally, final fasting blood sugar, abdom-
inal fat weight and serum cholesterol were remarkably
higher in group 2 than in groups 1 and 2, and signifi-
cantly higher in group 3 than in group 1.
Serial changes of circulating EPCs in three groups of
animals after CLI
The circulating numbers of EPCs, including C-kit/CD31+,
Sca-1/KDR+, CXCR4/CD34+ cells, did not differ among
animals in three groups prior to CLI induction. However,
Figure 2 Western blot results of fibrotic and anti-fibrotic biomarkers in ischemic muscle by day 14 after critical limb ischemia (CLI)
procedure (n = 9). A & B) protein expressions of transforming growth factor (TGF)-β and phosporylated-Smad3. * vs. other groups with different
symbols, p< 0.002. C & D) protein expressions of bone morphogenic protein (BMP)-2 and phosporylated-Smad1/5. * vs. other groups with
different symbols, p< 0.003. Statistical analysis by ANOVA followed by Bonferroni multiple comparison post hoc test.
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higher in group 3 than in groups 1 and 2 by 18 h after CLI
procedure (Table 1). Additionally, the circulating number of
C-kit/CD31+ EPC was notably higher in group 2 than in
group 1. However, other two circulating numbers of Sca-1/
KDR+, CXCR4/CD34+ EPCs did not differ between groups
1 and 2 at 18 h following the CLI procedure.
By day 14 after CLI induction, the circulating number of
C-kit/CD31+ EPC was still notably higher in group 3 than in
groups 1 and 2, but it showed no difference between latter
two groups. On the other hand, those circulating numbers
of Sca-1/KDR+and CXCR4/CD34+ EPCs were similar
among the three groups by 14 after CLI procedure (Table 1).
Adipose-derived endothelial progenitor cells (ADEPCs)
To determine whether weight reduction would affect EPC
differentiation in fat tissue, adipose-derived cells were cul-
tured in M199 culture medium (i.e., endothelial cell culture
medium) for 14 days, followed by flow cytometric analysis.
Interestingly, the numbers of ADEPCs, including C-kit/
CD31+, CXCR4/CD34+ (double staining) and CD133+ (i.e.,
single stain), were remarkably higher in group 3 than in
groups 1 and 2, and significantly higher in group 1 than in
group 2 (Figure 1). On the other hand, the number of Sca-1/KDR+ADEPC was similar between groups 1 and 2.
However, this biomarker was significantly higher in group 3
than in groups 1 and 2.
Protein expressions of fibrotic and anti-fibrotic
biomarkers in ischemic tissue
The protein expressions of TGF-β and phosphorylated-
Smad 3, two indexes of fibrosis in ischemic muscle, were
notably higher in group 2 than in groups 1 and 2, and
they were significantly higher in group 3 than in group 1
(Figure 2). By contrast, the protein expressions of BPM-2
and phosphorylated-Smad1/5, two anti-fibrotic biomar-
kers in ischemic muscle, were significantly lower in
group 2 than in groups 1 and 3, and notably lower in
group 3 compared to group 1.
Cytochrome C protein expression in mitochondria and
cytosol in ischemic tissue
The total mitochondrial cytochrome C protein expression
(Figure 3-A) was significantly lower in group 2 than that in
groups 1 and 3, and notably lower in group 3 than in group
1. Conversely, total amount of cytosolic cytochrome C pro-
tein expression (Figure 3-B) was significantly higher in group
2 than that in groups 1 and 3, but no significant difference
Figure 3 Western blot results of mitochondrial-storage and
inflammatory biomarkers by day 14 following CLI procedure (n=9).
A) protein expression of mitochondrial cytochrome C (Cyt C) in CLI
area. * vs. other groups with different symbols, p< 0.03. B) protein
expression of cytosolic Cyt C in CLI area. * vs. other groups with
different symbols, p< 0.003. C) Total protein expression of
intercellular adhesion molecule (ICAM)-1 in CLI area. * vs. other
groups with different symbols, p< 0.001. Statistical analysis by
ANOVA followed by Bonferroni multiple comparison post hoc test.
Figure 4 Western blot results of oxidative stress and angiogenic facto
oxidative index, protein carbonyls, in obesity animals than in normal and obesity
controls. * vs. other groups with different symbols, p< 0.005. (Note: Right lane an
protein standard and protein molecular weight marker, respectively). DNP=1-3 d
factor (SDF)-1α and CXCR4 were significantly enhanced in obesity-control mice th
other groups with different symbols, p< 0.02. Statistical analysis by ANOVA follow
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that the expression of cytochrome C, an index of energy
supply and storage in mitochondria, was notably lower in
group 2 than in groups 1 and 3. Besides, the increase in cyto-
solic cytochrome C content in group 2 also suggest signifi-
cant mitochondrial damage with cytochrome C release into
the cytosol in the ischemic muscle. These findings imply that
weight reduction significantly alleviated the intensity of oxi-
dative stress resulting from free radical production via a
change in permeability of the mitochondrial transition pore.
The protein expressions of inflammatory, oxidative stress
biomarkers and angiogenesis factors in ischemic tissue
The protein expression of ICAM-1 (Figure 3-C), an indicator
of inflammation, was markedly increased in group 2 than in
groups 1 and 3, and significantly increased in group 3 than
in group 1 by day 14 after the CLI procedure. Additionally,
Western blot analysis (Figure 4-A & 4-B) showed that mito-
chondrial oxidative stress was significantly higher in group 2
than that in groups 1 and 3, and notably higher in group 3
than in group 1.
The protein expressions of SDF-1α (Figure 4-C) and
CXCR4 (Figure 4-D), two indicators of angiogenesis in
muscle of ischemic area in response to ischemic stress, were
significantly increased in group 3 than in groups 1 and 2, but
there was no significant difference between groups 1 and 2.
These findings suggest that group 3 animals had enhanced
SDF-1α expression in ischemic tissue in response to ischemic
stimulation for attracting the homing of CXCR4+ cells into
the ischemic region to participate in angiogenesis.rs by day 14 after CLI procedure (n = 9). A & B) Significantly higher
controls, and significantly higher in obesity-control animals than in normal
d left lane shown on upper panel represent control oxidized molecular
initrophenylhydrazone. C & D) protein expressions of stromal cell-derived
an in obesity mice in response to ischemic stress in ischemic muscle. * vs.
ed by Bonferroni multiple comparison post hoc test.
Figure 5 Quantifications of endothelial cells (ECs) in ischemic region by day 14 after CLI procedure using immunofluorescent
microscope (400x) (n = 9). A to C) showing the numbers of CD31+ ECs (white arrows) remarkably higher in normal control (C) group than in
obesity (OB) and obesity control (OBC) groups, and significantly higher in OBC group than in OB group. D) * vs. other groups with different
symbols, p< 0.0001. E to G) showing the numbers of von Willebrand factor (vWF) + ECs (white arrows) notably higher in C group than in OB and
OBC groups, and significantly higher in OBC group than in OB group. G) * vs. other groups with different symbols, p< 0.0001. Statistical analysis
by ANOVA followed by Bonferroni multiple comparison post hoc test. The scale bars in right lower corner represent 20 μm.
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staining in ischemic tissue
IF staining showed that the numbers of CD31+ and vWF+
cells, two indicators of endothelial cell markers, were signifi-
cantly lower in group 2 than in groups 1 and 3, and notably
lower in group 3 than in group 1 on day 14 in ischemic tis-
sue after the CLI procedure (Figure 5).
IHC staining revealed remarkably lower number of small
vessels (≤ 15 μm in diameter) in ischemic muscle in group 2
than that in groups 1 and 3, and it was significantly lower in
group 3 compared with that in group 1 on day 14 following
CLI induction (Figure 6).
Laser Doppler analysis of blood flow
The ratio of ischemic/normal blood flow (INBF) did not differ
among groups 1, 2, and 3 prior to CLI induction. There was
also no significant difference between groups 2 and 3, but it
was markedly reduced in these two groups of animalscompared with that in group 1 on day 2 after the CLI proced-
ure (Figure 7). By day 14 after CLI induction, the ratio of
INBF was significantly reduced in group 2 than that in groups
1 and 3, and significantly lower in group 3 than in group 1.Discussion
The present study, which investigated the impact of
obesity control on the differentiation of ADEPCs, circu-
lating level of EPCs, and angiogenesis in response to is-
chemic stimulation, yields several striking implications.
First, obesity suppressed the ability of ADEPC differenti-
ation that was reversed by obesity control. Second, the
circulating level of EPCs in response to ischemia was
notably reduced in obesity as compared with obesity
control. Third, the angiogenic capacity in response to is-
chemic stimulation was markedly impaired in the obese
mice than in obesity control. Finally, the blood flow in
Figure 6 Immunohistochemical staining of alpha-smooth
muscle actin for quantification of small vessel (≤ 15.0 μm)
(200x) in ischemic quadriceps at day 14 after CLI induction
(n = 9). A to D) Significantly higher number of small vessels (≤ 15
μm) (red arrows) in normal control (C) group than in obesity (OB)
and obesity control (OBC) groups, and notably higher number in OBC
group than in OB group. * vs. other groups with different symbols,
p< 0.01. Statistical analysis by ANOVA followed by Bonferroni
multiple comparison post hoc test. Scale bars in right lower corner
represent 50 μm. HPF= high-power field (200x).
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mals but was significantly restored after obesity control.Figure 7 Laser Doppler scanning of hind limb blood flow on
day 14 after CLI induction (n = 9).Laser Doppler scanning of
hind limb blood flow on day 14 after CLI induction (n = 9). A to
C & D) Normal blood flow in both hind limbs in normal control (A),
obesity (B) and obesity control (C) prior to the procedure. E to G)
Significantly reduced ratio of ischemic/normal blood flow (INBF) in
obesity (F) group than in obesity control (G) and normal control (E)
groups, and notably lower in obesity control group than in normal
controls by day 14 after CLI procedure. H) * vs. other groups with
different symbols, p< 0.001. Statistical analysis by ANOVA followed
by Bonferroni multiple comparison post hoc test.Impact of obesity control on circulating level of EPCs in
response to ischemic stimulation
Obesity, which is a rapidly growing epidemic worldwide, is
commonly associated with a broad range of cardiovascular
diseases [1-8]. Although the association between increased
cardiovascular risk and decreased circulating number of
EPCs has been demonstrated in previous studies [13,19,20],
the impact of obesity on endothelial injury and dysfunction
[21] and circulating number of EPCs [7,22] has not been
fully examined. Besides, the effect of obesity control (i.e.,
body weight reduction) on vascular integrity has seldom
been explored [22], especially in a well-controlled study
using animal model. One important finding in the current
study is that, although the circulating numbers of EPCs (C-
kit/CD31+, Sca-1/KDR+, CXCR4/CD34+) showed no sig-
nificant difference among the control, obese, and obesity
control animals before CLI induction (Table 1), they were re-
markably reduced in obese mice at the acute stage (i.e. 18 h
after the CLI procedure) compared with that in the obesity
controls. Additionally, the circulating number of C-kit/CD31
+ cells remained notably higher in the obesity-controlled
mice than that in the obese animals at the recovery stage
(i.e., at day 14 after CLI). These findings, in addition to im-
plicating a poorer angiogenic response to ischemic stress in
the obese mice, also support the beneficial effects of weight
reduction from previous clinical observation studies [7,22].Beneficial effect of obesity control on enhancing the
differentiation of adipose-derived endothelial progenitor
cells (ADEPCs)
Growing data have shown distinct advantages of using adi-
pose-derived stem cells in improving ischemia-related organ
dysfunction [26,27]. However, whether obesity also influ-
ences the differentiation of ADEMPC is currently unclear.
Another important finding in the present study is that the
number of differentiated EPCs (C-kit+, CXCR4/CD34+,
CD133+) from adipose tissue after 14-day cell culturing was
significantly lower in the obese mice compared with that in
the normal controls. The number, on the other hand, was
restored to the level of the normal controls in obesity-con-
trolled mice. Interestingly, a previous study [23] has
Figure 8 Proposed mechanisms underlying the effects of obesity control (i.e., body weight reduction) on CLI in a murine model based
on the findings of the present study. BMP-2= bone morphogenic protein 2; Cyt-C = cytochrome C; EPC = endothelial progenitor cells; ICAM-
1 = intercellular adhesion molecule 1; SDF-1α= stromal cell-derived factor-1 alpha; TGF-β= transforming growth factor beta.
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eral blood-derived EPCs was notably impaired in over-
weight and obese adults. Accordingly, our findings not only
are comparable to those of a previous study [23], but also
highlight the possible therapeutic potential of obesity con-
trol in improving the capacity of ADEPC differentiation, es-
pecially in obese patients who are candidates for ADPEC
therapy due to ischemia-related organ dysfunction in our
future clinical practice.
Role of obesity reduction in attenuating inflammation,
oxidative stress, fibrosis, apoptosis, and mitochondrial
damage in ischemic tissue
The links among chronic inflammation, increased oxida-
tive stress, and cardiovascular diseases have been well
documented [28-31]. Additionally, apoptosis, fibrosis,
and degree of mitochondrial damage have been clearly
identified as useful biomarkers for predictive of outcome
in experimental studies of cardiovascular diseases
[17,25-28]. However, the relationship between obesity
and these biomarkers in the setting of organ ischemia
remains uncertain. An essential finding in the current
study is that the inflammatory, oxidative stress, fibrotic,
and mitochondrial damage biomarkers (Figures 2, 3 and
4) were substantially increased, whereas the anti-fibrotic
biomarkers were remarkably reduced in ischemic
muscle of obese animals compared to those in control
animals. These findings suggest that obesity mayparticipate in the up-regulation of these cardiovascular
disease-related biomarkers after an acute ischemic in-
sult. Of particular importance is that these inflamma-
tory, oxidative stress, fibrotic, and mitochondria damage
biomarkers were markedly decreased, whereas the anti-
fibrotic biomarkers were notably increased in the obese
mice after obesity control (Figures 2, 3 and 4). Our find-
ings, therefore, further support the benefit of obesity
control in ameliorating the risk for cardiovascular
diseases.
Probability of obesity control in improving angiogenesis
and blood flow in ischemic tissue
The principal finding in the present study is that the
protein expressions of CXCR4 and SDF-1α, two import-
antly angiogenic factors in response to ischemic stimula-
tion (Figure 4), were notably impaired in obese animals.
Additionally, as compared with the normal controls,
other angiogenic biomarkers, including immunofluores-
cent staining (CD31+ and vWF + cells) (Figure 5) and
neovascularization (i.e., number of small vessels) (Fig-
ure 6) were significantly lower in the ischemic muscle of
the obese animals by day 14 after the CLI procedure.
These parameters, on the other hand, were significantly
preserved after obesity control. Importantly, the blood
flow in ischemic muscle (Figure 7) was notably restored
in obese animals after obesity control compared to those
without. These findings again suggest a positive
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an ischemic insult.
Study limitations
This study has limitations. First, the exact mechanisms
underlying the partial restoration of angiogenic capacity after
control of obesity in this experimental setting of tissue ische-
mia remain unclear. The proposed mechanisms, which are
based on our findings, have been summarized in Figure 8.
Second, the lack of significant difference in the baseline level
of circulating EPCs among the three groups of animals was
unexpected. It could be due to the possibility that the dur-
ation of obesity induction was too short to initiate overt car-
diovascular damage in our experimental setting. Third, the
reason for the elevated number of a specific population of
ADEPCs (i.e., C-kit/CD31+, Sca-1/KDR+) in the obesity-
controlled mice compared to that in the normal controls
after 14-day cell culture is still unclear. It may be due to a
hyper-reactive response to ischemic stimulation that occurs
only at the early stage of weight reduction.
Conclusion
Obesity impaired elevation of circulating level of EPCs in
response to ischemic stimulation, hampered the differenti-
ation of EPCs from adipose tissue, and impeded the cap-
acity of angiogenesis and blood flow in ischemic tissue that
were significantly restored by obesity control in a murine
model of diet-induced obesity with limb ischemia.
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